Navigation Links
Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice
Date:4/8/2008

SHANGHAI, China, April 8, 2008 /Xinhua-PRNewswire-FirstCall/ -- Linkwell Corporation (Linkwell or the Company) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, today announced it will discuss its 2007 year-end financial results in a conference call on Wednesday, April 16, 2008, at 8:30 a.m. EDT.

The Company will release its 2007 year-end financial results on Tuesday, April 15, 2008. Hosting the call will be Linkwell Chairman and CEO Xuelian Bian, COO Arthur Huang, Corporate Secretary Rick Wang and investor relations consultant Craig Bird.

Conference Call

To participate in the conference call, callers from the USA and Canada please dial 800-257-2101, all other international callers please dial (303)-262-2130. All callers should dial in five to ten minutes prior to the conference call time.

Audio Stream and Webcast

You may also participate via live audio stream by logging onto http://www.investquest.com/iq/l/linkwell/ . A rebroadcast of the audio stream will be available using the same web link for 90 days after the initial broadcast.

Linkwell also announced the revised dates for its non-deal road show in the USA to April 16-22, 2008. Investors interested in meeting with Linkwell COO, Mr. Arthur Huang should contact investor relations, Craig Bird, at (215)-885-4981.

About Linkwell Corporation

Linkwell Corporation develops, manufactures and distributes disinfectant healthcare products in China through its subsidiary Shanghai LiKang Disinfectant High Tech Company ("LiKang"). Linkwell's disinfectant healthcare products are a nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectants in liquid, tablet, powder and aerosol form. Through LiKang, Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. For more information, please visit http://www.linkwell.us .

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products, pricing and new technology; changes in consumer preferences and tastes; effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production; and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Investor Relations

Craig Bird

Segue Ventures LLC

Tel: +1-215-885-4981

Email: chbird@segue.biz


'/>"/>
SOURCE Linkwell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K
2. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
3. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
4. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
5. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 8:00am ET
6. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
7. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET
8. Pet DRx Corporation Reports 2007 Financial Results
9. Dialysis Corporation of America Announces the Development of a New Facility in Pennsylvania
10. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
11. Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... Fort Stewart, GA (PRWEB) , ... April 29, 2016 , ... ... on Monday, May 16, 2016, at its new location in the Exchange Furniture Mall ... including a raffle for a 50-inch Samsung Smart TV. Plus attendees will have the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston Medical ... neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse ... is a newly patented safety device secured by nasal surgeons onto the floor of ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 ReportsnReports.com adds ... market research report that provides an overview of ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
Breaking Medicine Technology: